statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Purple Biotech Ltd. (NASDAQ:PPBT - Get Free Report)'s share price was up 9.7% during trading on Thursday . The company traded as high as $0.67 and last traded at $0.67. Approximately 98,128 shares...

Purple Biotech (NASDAQ:PPBT) Trading 9.7% Higher

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Purple Biotech reports Q4 EPS (19c), consensus (19c)

Purple Biotech convenes a head, neck cancer SAB ahead of NT219 trial

Purple Biotech Ltd. (NASDAQ:PPBT  Get Free Report)s stock price rose 3.2% during mid-day trading on Wednesday . The stock traded as high as $0.82 and last traded at $0.80. Approximately...

Purple Biotech (NASDAQ:PPBT) Stock Price Up 3.2%

Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through two segments: Oncology, and Pain & Hypertension. The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance mechanisms, and which is currently in the late pre-clinical stage of development. The Pain & Hypertension segment includes Consensi, a combination drug for the simultaneous treatment of two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existing or caused by the treatment for osteoarthritis. The company was founded by John Paul Waymack on August 12, 1968 and is headquartered in Rehovot, Israel.

Purple Biotech Ltd - ADR

Volume	176,664.00
52-Wk High	$2.08
52-Wk Low	$0.3023

PPBT Purple Biotech Ltd - ADR

About

Feed

News

Sentiment

Fundamentals